Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers
Chimeric Antigen Receptor T-cell (CAR-T) therapy has transformed the treatment landscape for hematological malignancies, showing high efficacy in patients with relapsed or refractory (R/R) disease and otherwise poor prognosis in the pre-CAR-T era. Thes…